Showing results (161-170 of 635) with videos related to
Sort By:
Pageof 64
Journal of Clinical & Laboratory Immunology|October 1, 1984
Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF)D Kowalczyk, M Staykowa, E Litwora, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 1, 1992
Epidermal growth factor (EGF) expression in human salivary glands. An immunohistochemical studyB Dubiel, B Mytar, A Tarnawski, et al.Transplantation Proceedings|October 8, 2003
Limited utility of cyclosporine C2 monitoring in heart transplant recipients receiving ketoconazoleM Zakliczynski, A Krynicka, M Szewczyk, et al.Kardiologia Polska|January 6, 2012
Percutaneous dilatation of coarctation of the aorta, stenotic pulmonary arteries or homografts, and stenotic superior vena cava using Andrastents XL and XXLJacek Białkowski, Małgorzata Szkutnik, Roland Fiszer, et al.Wiadomosci Lekarskie (Warsaw, Poland : 1960)|April 1, 1994
[Concentration of myoglobin in serum in patients with heart transplantation]W Pokrzywnicki, W Grzeszczak, A Kochańska, et al.Immunology Letters|January 1, 1995
Modulation of monocyte antigen-presenting capacity by tumour necrosis factor-alpha (TNF): opposing effects of exogenous TNF before and after an antigen pulse and the role of TNF gene activation in monocytesD Kowalczyk, B Mytar, M Jasiński, et al.Cellular Immunology|October 15, 1985
I-A region genetic restriction in the production and action of an antigen-specific T-helper factor which bears I-A region determinant(s)V Colizzi, G L Asherson, M Zembala, et al.Neoplasma|January 1, 1986
Immunological reactivity in children with Wilms' tumorD Kowalczyk, S Szymik, J Grochowski, et al.Annals of Transplantation|April 8, 2020
Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft VasculopathyŁukasz Pyka, Michał Hawranek, Bożena Szyguła-Jurkiewicz, et al.Immunology|October 1, 1985
Monocyte subsets in the production of inhibitory factor by Candida albicans-activated human T cellsG Lombardi, E Piccolella, D Vismara, et al.Pageof 64